S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA

• Franco Locatelli,
• Peter Lang,
• Selim Corbacioglu,
• Amanda LI,
• Josu De La Fuente,
• Donna Wall,
• Roland Meisel,
• Ami J. Shah,
• Robert Liem,
• Markus Mapara,
• Ben Carpenter,
• Janet Kwiatkowski,
• Maria Domenica Cappellini,
• Antonis Kattamis,
• Sujit Sheth,
• Stephan Grupp,
• Puja Kohli,
• Daoyuan Shi,
• Leorah Ross,
• Yael Bobruff,
• Christopher Simard,
• Lanju Zhang,
• Phuong Khanh Morrow,
• Bill Hobbs,
• Haydar Frangoul

Affiliations

Franco Locatelli

1 IRCCS, Ospedale Pediatrico Bambino Gesù Rome, Catholic University of the Sacred Heart, Rome, Italy

Peter Lang

2 University of Tübingen, Tübingen, Germany

Selim Corbacioglu

3 University of Regensburg, Regensburg, Germany

Amanda LI

4 BC Children’s Hospital, University of British Columbia, Vancouver, Canada

Josu De La Fuente

5 Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, United Kingdom

Donna Wall

6 The Hospital for Sick Children/University of Toronto, Toronto, Canada

Roland Meisel

7 Heinrich-Heine-University, Duesseldorf, Germany

Ami J. Shah

8 Stanford University, Palo Alto, United States

Robert Liem

9 Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, United States

Markus Mapara

10 Herbert Irving Comprehensive Cancer Center, Columbia University, New York, United States

Ben Carpenter

11 University College London Hospitals NHS Foundation Trust, London, United Kingdom

Janet Kwiatkowski

12 Children’s Hospital of Philadelphia, Philadelphia, United States

Maria Domenica Cappellini

13 University of Milan, Milan, Italy

Antonis Kattamis

14 University of Athens, Athens, Greece

Sujit Sheth

15 Joan and Sanford I Weill Medical College of Cornell University, New York, United States

Stephan Grupp

16 Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States

Puja Kohli

17 Vertex Pharmaceuticals Incorporated, Boston, United States

Daoyuan Shi

17 Vertex Pharmaceuticals Incorporated, Boston, United States

Leorah Ross

17 Vertex Pharmaceuticals Incorporated, Boston, United States

Yael Bobruff

17 Vertex Pharmaceuticals Incorporated, Boston, United States

Christopher Simard

17 Vertex Pharmaceuticals Incorporated, Boston, United States

Lanju Zhang

17 Vertex Pharmaceuticals Incorporated, Boston, United States

Phuong Khanh Morrow

18 CRISPR Therapeutics, Cambridge, United States

Bill Hobbs

17 Vertex Pharmaceuticals Incorporated, Boston, United States

Haydar Frangoul

19 Sarah Cannon Center for Blood Cancer at The Children’s Hospital at TriStar Centennial, Nashville, United States